Rasoul Pourebrahim

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Rasoul Pourebrahim

Dec 13, 2024, 05:16 | Insight

MD Anderson Research Highlights: ASH 2024 Special Edition

Featuring novel treatments and research insights for MDS, leukemia, and lymphoma, encouraging long-term trial data,…

May 17, 2024, 04:29 | Insight

Rasoul Pourebrahim: New potential targets for preventing AML with p53 mutations

Rasoul Pourebrahim, Assistant Professor at MD Anderson Cancer Centre, shared on LinkedIn: "Our paper was…

May 12, 2024, 06:02 | Insight

Rasoul Pourebrahim: Our latest publication on studying mutant p53-driven Acute Myeloid Leukemia

Rasoul Pourebrahim, Assistant Professor at MD Anderson, made the following post on LinkedIn: "Our paper…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023